Home009420 • KRX
add
Hanall Biopharma Co Ltd
Previous close
₩24,900.00
Day range
₩24,850.00 - ₩25,400.00
Year range
₩24,200.00 - ₩52,000.00
Market cap
1.31T KRW
Avg Volume
143.83K
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (KRW) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 36.15B | 6.03% |
Operating expense | 19.59B | 6.00% |
Net income | -207.51M | 35.82% |
Net profit margin | -0.57 | 40.00% |
Earnings per share | — | — |
EBITDA | 500.27M | -45.25% |
Effective tax rate | 49.07% | — |
Balance Sheet
Total assets
Total liabilities
| (KRW) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 13.55B | -71.88% |
Total assets | 195.72B | -11.65% |
Total liabilities | 36.41B | -15.92% |
Total equity | 159.30B | — |
Shares outstanding | 50.79M | — |
Price to book | 7.94 | — |
Return on assets | -0.48% | — |
Return on capital | -0.60% | — |
Cash Flow
Net change in cash
| (KRW) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -207.51M | 35.82% |
Cash from operations | 850.34M | 9.61% |
Cash from investing | -3.76B | 7.74% |
Cash from financing | 68.37M | 151.15% |
Net change in cash | -2.84B | 17.18% |
Free cash flow | -10.00B | -2.60% |
About
Founded
1973
Headquarters
Website
Employees
304
